Jazz Pharmaceuticals saw the highest growth of 149% in patent filings in January and 149% in grants in March in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 149% and grants by 99%. GlobalData’s DataBook provides a comprehensive analysis of Jazz Pharmaceuticals‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Jazz Pharmaceuticals has been focused on protecting inventions in United States(US) with 13 publications in Q1 2024

The United States(US) Patent Office dominates the patent filings and grants with nearly 23% filings and 12% grants. The United States(US), South Korea(KR), World Intellectual Property Organization(WIPO), and European Patent Office(EPO) patent Office are among the top ten patent offices where Jazz Pharmaceuticals is filings its patents. Among the top granted patent authorities, Jazz Pharmaceuticals has 25% of its grants in Israel(IL), 12% in United States(US) and 6% in South Korea(KR).

F. Hoffmann-La Roche could be the strongest competitor for Jazz Pharmaceuticals

Patents related to rare diseases and addiction lead Jazz Pharmaceuticals's portfolio

Jazz Pharmaceuticals has the highest number of patents in rare diseases followed by, addiction and nanomedicine. For rare diseases, nearly 44% of patents were filed and 38% of patents were granted in Q1 2024.

Epilepsy related patents lead Jazz Pharmaceuticals portfolio followed by seizures, and lymphoma

Jazz Pharmaceuticals has highest number of patents in epilepsy followed by seizures, lymphoma, dravet syndrome (severe myoclonic epilepsy of infancy), and mobiles, hand-helds, pdas, smartphones. For epilepsy, nearly 13% of patents were filed and 3% of patents were granted in Q1 2024.

For comprehensive analysis of Jazz Pharmaceuticals's filings and grants, buy the databook here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.